Connection
Search Results to
This is a "connection" page, showing the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of
Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.
| Property | Value |
|
has major subject area list
|
Antidepressive Agents, Tricyclic; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Genotyping Techniques; Medication Therapy Management; Pharmacogenomic Variants
|
|
information resource reference
|
Hicks JK, Sangkuhl K, Swen JJ, Ellingrod VL, M?ller DJ, Shimoda K, Bishop JR, Kharasch ED, Skaar TC, Gaedigk A, Dunnenberger HM, Klein TE, Caudle KE, Stingl JC. Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update. Clin Pharmacol Ther. 2017 07; 102(1):37-44.
|
|
label
|
Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.
|